Mechanisms of sulbactam-durlobactam resistance in Acinetobacter baumannii.
Metallo-β-lactamases, PBP3 alterations, and efflux overexpression drive sulbactam-durlobactam resistance in Acinetobacter baumannii.
- Why it matters: Understanding resistance mechanisms is crucial for improving treatment strategies against carbapenem-resistant A. baumannii, a significant clinical threat with limited options.
- What they did: The study reviews known resistance pathways, including metallo-β-lactamases, PBP3 modifications, and efflux pump overproduction, highlighting gaps in mechanistic validation and the impact of carbapenem addition.
- The result: Clarifying these mechanisms will inform better diagnostic and therapeutic approaches, potentially guiding the development of more effective agents against resistant A. baumannii.